CSL Group collaborated with global plasma leaders to accelerate development of COVID-19 hyperimmune therapy
On Apr. 6, 2020, Biotest, BPL Group, LFB, and Octapharma joined an alliance formed by CSL Behring and…
RedHill Biopharma announced approval of Compassionate Use of Opaganib for COVID-19 in Italy
On Apr. 6, 2020, RedHill Biopharma announced it has received authorization from the Italian National Institute for Infectious…
COVID-19 | FDA | Infectious Disease | Vaccine
INOVIO initiated phase 1 clinical trial of its COVID-19 vaccine
On Apr. 6, 2020, Inovio Pharma announced the U.S. Food and Drug Administration (FDA) had accepted the company’s…
New COVID-19 forecasted for Europe: Italy & Spain have passed the peak of their epidemics; UK faces a fast-mounting death toll
On Apr. 6, 2020, Sema4 announced that it is now performing rapid molecular testing for the detection of…
USDA confirmed COVID-19 in a tiger in New York Zoo
On Apr. 6, 2020, the USDA confirmed SARS-CoV-2 (the virus that causes COVID-19 in humans) in one tiger…
COVID-19 | FDA | Therapeutics
FDA cleared Mesoblast IND for remestemcel use in COVID-19 ARDS patients
On Apr. 6, 2020, Mesoblast announced it had received clearance from the U.S. Food and Drug Administration (FDA)…
Luminex received FDA Emergency Use Authorization for ARIES SARS-CoV-2 assay to detect virus responsible for COVID-19 disease
On Apr. 6, 2020, Luminex announced announced that the FDA has issued an Emergency Use Authorization for its…
GSK and Vir Biotechnology entered collaboration to find coronavirus solutions
On Apr. 6, 2020, GSK and Vir Biotechnology announced a binding agreement to enter into a collaboration to…
VGXI supported rapid timeline to clinical testing for Coronavirus vaccine
On Apr. 6, 2020, VGXI, announced it had completed manufacturing and release of a DNA vaccine to combat…
IGEA Pharma supplied COVID-19 antibody-based test in the US
On Apr. 6, 2020, IGEA Pharma announced that it was starting to supply of a COVID-19 antibody test…
Rice University established COVID-19 research fund
On Apr. 6, 2020, Rice University announced it had established a research accelerator fund to support projects –…
Intravacc partnered with Wageningen Bioveterinary Research and Utrecht University to develop intranasal COVID-19 vaccine
On Apr. 6, 2020, Intravacc announced development of an intranasal vaccine against COVID-19 that will be developed through…
Mateon achieved milestone in development of OT-101, a phase 3 clinical drug candidate, against COVID-19
On Apr. 6, 2020, Mateon Therapeutics announced an update on its rapid antiviral response program targeting coronaviruses, initially…
OncoSec collaborated with Providence Cancer Institute to conduct first-in-human trial of CORVax12, an Investigational Vaccine to prevent COVID-19
On Apr. 6, 2020, OncoSec Medical announced that Providence Cancer Institute, a part of Providence St. Joseph Health…
Sema4 launched high-capacity COVID-19 testing to address critical need across Connecticut and New York
On Apr. 6, 2020, new COVID-19 estimated find that, among European nations, the peak daily death rate from…
AIM ImmunoTech and Shenzhen Smoore Technology announced research agreement to develop, easy-to-use treatment approach for the SARS-CoV-2 Pandemic
On Apr. 6, 2020, AIM ImmunoTech announced a Material Transfer and Research Agreement (MTA) with Shenzhen Smoore Technology…
New IHME COVID-19 forecasts find lower hospital bed need, epidemics starting to peak confirms social distancing works
On Apr. 5, 2020, updated COVID-19 estimates from the Institute for Health Metrics and Evaluation (IHME) found that…
Minneapolis Heart Institute Foundation engaged in COVID-19 STEMI research study
On Apr. 6, 2020, the Minneapolis Heart Institute Foundation (MHIF) announced it was serving as the international coordinating…
Mary and Ryan Finley donated $3 million to Legacy Health, OHSU to combat COVID-19
On Apr. 3, 2020, Oregon Health & Science University (OHSU) announced that Mary and Ryan Finley, moved by…
Penn Medicine launched trial to evaluate hydroxychloroquine to treat, prevent COVID-19
On Apr. 3, 2020, a trial led by the Perelman School of Medicine at the University of Pennsylvania…
XBiotech and BioBridge Global collaborate on FDA program to develop potential COVID-19 antibody-based treatment
On Apr. 3, 2020, XBiotech and BioBridge Global announced a collaboration to participate in a FDA investigational program…
Mayo Clinic named national site for Convalescent Plasma Expanded Access Program
On Apr. 3, 2020, the FDA announced that the Mayo Clinic Mayo Clinic will be the lead institution…
University of Minnesota created on-site testing facility for COVID-19
On Apr. 3, 2020, the University of Minnesota announced it had created the stateﾒs fourth on-site testing facility…
University of Nebraska developed a COVID-19 screening mobile app
On Apr. 3, 2020, UNMC aunched a groundbreaking mobile app for Apple Iphone to screen large groups of…
COVID-19 | Diagnostics | FDA
BD, BioGX announced FDA Emergency Use Authorization for new COVID-19 diagnostic for use in U.S.
On Apr. 3, 2020, BD (Becton, Dickinson) and BioGX announced that the U.S. Food and Drug Administration (FDA)…
Clinical trial for severely ill COVID-19 patients begun at Montefiore-Einstein
On Apr. 3, 2020, Montefiore Health System and Albert Einstein College of Medicine started treating very sick COVID-19…
OHSU launched in-house COVID-19 testing lab
On Apr. 3, 2020, Oregon Health & Science University (OHSU) announced that it had established an in-house COVID-19…
Vanda Pharma announced initiation of FDA approved clinical study of Tradipitant patients with severe COVID-19 pneumonia
On Apr. 2, 2020, Vanda Pharmaceuticals announced initiation of clinical study, ODYSSEY VLY-686-3501, in hospitalized patients with COVID-19….
Biotechnology | COVID-19 | FDA | Therapeutics
Incyte initiated phase 3 clinical trial of Ruxolitinib (Jakafi) as treatment for patients with COVID-19 cytokine storm
On Apr. 2, 2020, Incyte announced it was working with the U.S. Food and Drug Administration (FDA) to…
Emergent BioSolutions partnered with U.S. Government to expedite development of plasma-derived therapy for COVID-19
On Apr. 2, 2020, Emergent BioSolutions announced it had entered into a formal partnership with the U.S. government…